AzTrials
AzTrials

Early Childhood CariesNCT04456335

Investigation of Supragingival Plaque Microbiome in Early Childhood Caries

An observational study of Early Childhood Caries, run by Trakya University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study was to characterize the supragingival plaque microbiome in children with early childhood caries and identify potential microorganisms associated with caries. Read more about this study

Who is it for?
Ages 36 to 71 months
Conditions the study is for
Early Childhood Caries
What is being tested?
Collection of supragingival plaque from caries free children
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
4 Mar 2019to 23 May 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 36 to 71 months
  • All sexes
  • Child

Study population: A total of sixty children with early childhood caries(n=30) and caries free(n=30)

Who may be able to join

  • 36-71 months old children
  • No history of any medical problem
  • No history of antibiotic in the three months prior to sampling
  • Any sign of early childhood caries,
  • Caries free children
  • Mothers accepted to complete a structured questionnaire
  • Children who cooperate for dental examination and sample collection

Who cannot join

  • Children older than 71 months
  • Medically compromised
  • Children with antibiotic use history at last three months
  • Children refused dental examination and plaque collection
  • Mothers' refused to complete questionnare

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Trakya Universitiy Faculty of Dentistry Department of Pediatric Dentistry

    Edirne, 22030

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of Supragingival Plaque Microbiome Using Next Generation Sequencing in Early Childhood Caries

The purpose of this study was to characterize the supragingival plaque microbiome in children with early childhood caries and identify potential microorganisms associated with caries.

Read the detailed description

Sixty children with and without early childhood caries were recruited from Trakya University Faculty of Dentistry Department of Pediatric Dentistry. Oral examinations were performed by the same examiner according to diagnostic criteria of World Health Organisation (WHO) and The International Caries Detection and Assessment System (ICDAS) . Mothers' completed a structured questionnaire on the socio-demographic informations, child's feeding practices and oral hygiene habits. After the oral examination, supragingival plaque samples were collected from the posterior tooth surfaces. Supragingival plaque samples were examined with the Illumina MiSeq new generation sequencing method.

Being tested
Collection of supragingival plaque from caries free children
Keywords
Early childhood caries, Oral Microbiome, Next generation sequencing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Collection of supragingival plaque from caries free childrenGenetic

    Also called Collection of supragingival plaque from children with early childhood caries

    Supragingival plaque samples were collected from posterior molar teeth

Study groups in NCT04456335
Study groupRoleWhat they receive
Caries-freeCaries-free children
Receives: Genetic: Collection of supragingival plaque from caries free children
Early childhood cariesChildren with early childhood caries
Receives: Genetic: Collection of supragingival plaque from caries free children

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. V4-16S rRNA and ITS1 rRNA sequencing

    Supragingival plaque samples were collected from the tooth surfaces using a sterile periodontal curette. DNA extraction was performed at Sugenomik Biotechnology Laboratory for library preparation and paired-end Illumina MiSeq PE250 sequencing of the V4 region of bacterial 16S rRNA and fungal ITS1 (internal transcribed spacer 1) rRNA genes.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jul 2020
  2. Study start4 Mar 2019
  3. Primary completion3 Jan 2020
  4. Study completion23 May 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Other
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04456335
Sponsor's protocol ID
2018/269
Status last verified
Jun 2020
First submitted
18 Jun 2020
Last updated
2 Jul 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Early Childhood Caries, run by Trakya University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

V4-16S rRNA and ITS1 rRNA sequencing (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in